CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 89 filers reported holding CHINOOK THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $583,843 | -11.6% | 25,220 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $660,764 | +4.6% | 25,220 | -21.5% | 0.00% | 0.0% |
| Q3 2022 | $632,000 | +31.1% | 32,140 | +3.7% | 0.00% | +33.3% |
| Q1 2021 | $482,000 | -47.1% | 30,985 | -46.2% | 0.00% | -40.0% |
| Q4 2020 | $912,000 | +25.1% | 57,541 | -80.8% | 0.01% | 0.0% |
| Q3 2020 | $729,000 | – | 300,079 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 5 | $0 | 0.00% |